You are here

Chiasma

Chiasma secures FDA approval for acromegaly pill Mycapssa years after near-catastrophic rejection

Fierce Pharma

Mon, 06/29/20 - 06:20 pm

Upcoming events – Phase III data for Chiasma and Novartis

EP Vantage

Fri, 05/17/19 - 07:23 pm

clinical trials

multiple sclerosis

The FDA's promo police slap four more pharmas in year-end enforcement spree

Fierce Pharma

Thu, 12/29/16 - 10:26 am

United-Guardian

Chiasma slashes staff as problems persist

BioPharma Dive

Thu, 08/18/16 - 08:54 am

Chiasma to cut one-third of its workforce as part of restructuring

Marketwatch

Tue, 06/14/16 - 10:06 am

Chiasma CEO says company may challenge FDA over rare-disease drug rejection

Bizjournals.com

Thu, 05/12/16 - 09:46 am

Chiasma's Acromegaly Drug Headed for FDA Rejection, Investor Says

TheStreet.com

Thu, 04/14/16 - 10:08 am

2 FDA Actions To Watch In April

Seeking Alpha

Mon, 03/28/16 - 09:12 pm

Sarepta Therapeutics

Duchenne Muscular Dystrophy

With Roche out the door, Chiasma is raising $56M to go it alone

Fierce Biotech

Fri, 01/2/15 - 10:50 am

Firm ranks top 5 biotech deals in evolving pharma R&D landscape

Fierce Biotech

Fri, 04/12/13 - 01:56 pm